Seeking Alpha

Zoll Medical Corporation (ZOLL)

ZOLL is defunct since April 30, 2012. acquired by a private company
  • Mar. 24, 2013, 5:32 AM
    The FDA has proposed new rules that would require the makers of emergency defibrillators to submit data clinical-trial data for their devices or provide other evidence that they work. The move comes after 45,000 malfunctions and 88 product recalls from 2005-2012. Leading manufacturers include Philips (PHG), Physio-Control and Zoll Medical (ZOLL).
    | Comment!
  • Apr. 19, 2012, 6:54 AM
    S&P names OpenTable (OPEN) and Spectrum Pharmaceuticals (SPPI) as new additions to the S&P SmallCap 600 to replace set-to-be-acquired Zoll Medical (ZOLL) and Midas (MDS).
    | Comment!
  • Apr. 2, 2012, 12:21 PM
    Lazard Capital downgrades a number of names in the in the Medical Technology space today due to valuation. Intuitive Surgical (ISRG +0.2%), Endologix (ELGX -5.4%), Allergan (AGN -0.4%), St. Jude Medical (STJ -0.7%) and ZOLL Medical (ZOLL +0.1%) are all cut to Neutral.
    | 1 Comment
  • Mar. 12, 2012, 9:00 AM
    Premarket gainers: TUDO +203%. KUTV +33%. ZOLL +24%. YOKU +20%. OREX +15%. FCEL +9%. RENN +9%. DANG +8%. SINA +4%.
    Losers: ANTH -51%. HGSI -4%. TLK -3%.
    | Comment!
  • Mar. 12, 2012, 4:53 AM
    Japan's Asahi Kasei Corp. agrees to buy Zoll Medical Corp. (ZOLL) for $2.21B, or $93/share, a 24% premium over Zoll's Friday closing price. Asahi Kasei, Japan’s leading diversified chemical manufacturer, see emerging demand for healthcare as a strategic sector for the company in the future. (PR)
    | Comment!
  • Jan. 20, 2012, 3:56 PM
    SunTrust Robinson Humphrey rings in on Zoll Medical (ZOLL +5.5%) after its solid FQ1 result late yesterday, calling it a "phenomenal margin expansion story" and naming it as its top pick in the medical devices space. The firm expects its emerging businesses to rack up 30-40% growth over the next few years.
    | Comment!
  • Jan. 20, 2012, 9:58 AM
    Zoll Medical (ZOLL +5.8%) surges at the open following strong FQ1 results which showed revenue from its LifeVest wearable defibrillator worn by patients at risk for sudden cardiac arrest, jumped 45% to $32.3M and now accounts for 20% of revenue. Zoll seems back on track after the strong quarter and Medicare's recent reversal of a decision to change its coverage policy.
    | Comment!
  • Jan. 19, 2012, 4:52 PM
    Zoll Medical (ZOLL): FQ1 EPS of $0.18 misses by $0.09. Revenue of $133.8M (+18% Y/Y) in-line. (PR)
    | Comment!
  • Dec. 15, 2011, 10:47 AM
    Zoll Medical (ZOLL +11.7%) announces that CMS coverage for its LifeVest Wearable Defribrillator was reaffirmed after it received positive support across the cardiology-focused community. Shares will actively trade again at 11:00 AM EST after being halted.
    | 1 Comment
  • Dec. 15, 2011, 10:05 AM
    Trading on Zoll Medical (ZOLL) is halted pending a news announcement. Shares were up 11% before the stop in action.
    | Comment!
  • Nov. 17, 2011, 9:42 AM
    Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the year-ago period and better than analyst estimates of $0.49, and a 65% rise in profit on strong sales of its LifeVest device. The maker of defibrillators forecasts 2012 revenue will rise as much as 19% vs. analyst consensus of ~16%, and reports a $50M share buyback program.
    | Comment!
  • Aug. 8, 2011, 3:41 PM
    ZOLL Medical (ZOLL -24%) gets crushed after revealing it's facing a potential revision by Medicare over how much it will pay to cover the cost of the company's defibrillators, including its LiveVest product. The outlined cuts could have "a material adverse effect on its LifeVest business," the company says.
    | Comment!
  • Jul. 29, 2011, 11:46 AM
    Zoll Medical (ZOLL +25%) soars after FQ3 earnings easily blows out estimates. Revenues jumped 22% Y/Y, driven by higher defibrillator sales after larger hospitals - who have been sitting on the sidelines for the past couple of years - are stepping up purchases.
    | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for ZOLL.